HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock Fundamental Analysis

NASDAQ:HAO • KYG4290F1182

1.21 USD

0 (0%)

Last: Feb 17, 2026, 01:46 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Fundamental Rating

Taking everything into account, HAO scores 5 out of 10 in our fundamental rating. HAO was compared to 92 industry peers in the Media industry. While HAO has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, HAO is valued expensive at the moment.

Quickly go to:

1. Profitability 2. Health 3. Growth 4. Valuation 5. Dividend

1. Profitability

1.1 Basic Checks

HAO had positive earnings in the past year.
In the past year HAO has reported a negative cash flow from operations.

1.2 Ratios

Looking at the Return On Assets, with a value of 13.23%, HAO belongs to the top of the industry, outperforming 97.83% of the companies in the same industry.
HAO has a Return On Equity of 18.20%. This is amongst the best in the industry. HAO outperforms 93.48% of its industry peers.
HAO has a Return On Invested Capital of 15.84%. This is amongst the best in the industry. HAO outperforms 98.91% of its industry peers.

		Industry Rank	Sector Rank
ROA	13.23%
ROE	18.2%
ROIC	15.84%

ROA(3y)25.06%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of HAO (2.85%) is better than 75.00% of its industry peers.
HAO's Profit Margin has improved in the last couple of years.
HAO has a Operating Margin (3.52%) which is comparable to the rest of the industry.
HAO's Operating Margin has improved in the last couple of years.
HAO has a worse Gross Margin (5.49%) than 83.70% of its industry peers.
In the last couple of years the Gross Margin of HAO has grown nicely.

		Industry Rank	Sector Rank
OM	3.52%
PM (TTM)	2.85%
GM	5.49%

OM growth 3Y11.17%

OM growth 5YN/A

PM growth 3Y4.01%

PM growth 5YN/A

GM growth 3Y6.32%

GM growth 5YN/A

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HAO is creating value.
HAO has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, HAO has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 16.30 indicates that HAO is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 16.30, HAO belongs to the best of the industry, outperforming 98.91% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that HAO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, HAO is in the better half of the industry, outperforming 71.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Altman-Z	16.3

ROIC/WACC2.12

WACC7.48%

2.3 Liquidity

A Current Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.98, HAO belongs to the best of the industry, outperforming 94.57% of the companies in the same industry.
A Quick Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.98, HAO belongs to the top of the industry, outperforming 94.57% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.98
Quick Ratio	3.98

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 120.64% over the past year.
Measured over the past years, HAO shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.74% on average per year.
Looking at the last year, HAO shows a very strong growth in Revenue. The Revenue has grown by 92.62%.
HAO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.73% yearly.

EPS 1Y (TTM)120.64%

EPS 3Y58.74%

EPS 5YN/A

EPS Q2Q%38.76%

Revenue 1Y (TTM)92.62%

Revenue growth 3Y55.73%

Revenue growth 5YN/A

Sales Q2Q%71.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.71 indicates a rather cheap valuation of HAO.
Based on the Price/Earnings ratio, HAO is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, HAO is valued rather cheaply.

		Industry Rank	Sector Rank
PE	0.71
Fwd PE	N/A

4.2 Price Multiples

HAO's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	25.44

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. Dividend

5.1 Amount

No dividends for HAO!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks Show peers with best dividend

HAOXI HEALTH TECHNOLOGY LTD

NASDAQ:HAO (2/17/2026, 1:46:44 PM)

1.21

0 (0%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.12%

Inst Owner Change0%

Ins Owners3.12%

Ins Owner ChangeN/A

Market Cap71.67M

Revenue(TTM)72.02M

Net Income(TTM)2.05M

Analysts0

Price TargetN/A

Short Float %0.09%

Short Ratio1.6

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	0.71
Fwd PE	N/A
P/S	1
P/FCF	N/A
P/OCF	N/A
P/B	6.36
P/tB	6.36
EV/EBITDA	25.44

EPS(TTM)1.7

EY140.5%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS1.22

BVpS0.19

TBVpS0.19

PEG (NY)N/A

PEG (5Y)N/A

Graham Number2.7

Profitability

		Industry Rank	Sector Rank
ROA	13.23%
ROE	18.2%
ROCE	21.78%
ROIC	15.84%
ROICexc	35.58%
ROICexgc	35.58%
OM	3.52%
PM (TTM)	2.85%
GM	5.49%
FCFM	N/A

ROA(3y)25.06%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)19.92%

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y11.17%

OM growth 5YN/A

PM growth 3Y4.01%

PM growth 5YN/A

GM growth 3Y6.32%

GM growth 5YN/A

F-Score3

Asset Turnover4.64

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Debt/EBITDA	0.45
Cap/Depr	522.64%
Cap/Sales	0.08%
Interest Coverage	67.98
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.98
Quick Ratio	3.98
Altman-Z	16.3

F-Score3

WACC7.48%

ROIC/WACC2.12

Cap/Depr(3y)486.59%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.11%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)120.64%

EPS 3Y58.74%

EPS 5YN/A

EPS Q2Q%38.76%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)92.62%

Revenue growth 3Y55.73%

Revenue growth 5YN/A

Sales Q2Q%71.88%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y50.42%

EBIT growth 3Y73.12%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y12.49%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y14.28%

OCF growth 3YN/A

OCF growth 5YN/A

HAOXI HEALTH TECHNOLOGY LTD / HAO FAQ

What is the ChartMill fundamental rating of HAOXI HEALTH TECHNOLOGY LTD (HAO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HAO.

Can you provide the valuation status for HAOXI HEALTH TECHNOLOGY LTD?

ChartMill assigns a valuation rating of 3 / 10 to HAOXI HEALTH TECHNOLOGY LTD (HAO). This can be considered as Overvalued.

What is the profitability of HAO stock?

HAOXI HEALTH TECHNOLOGY LTD (HAO) has a profitability rating of 5 / 10.

How financially healthy is HAOXI HEALTH TECHNOLOGY LTD?

The financial health rating of HAOXI HEALTH TECHNOLOGY LTD (HAO) is 7 / 10.